Humatica advises Capvis on their recent investment in Xovis
By Humatica
Humatica AG was retained to advise Capvis on its majority investment stake in Xovis, the global leader in people flow measurement and analytics. With the support of Capvis, Xovis’ management will continue to focus on growth and plans to enter new markets and business segments.
Humatica provided organisational due diligence services for this transaction.
To view the Press Release: Humatica advises Capvis on their recent investment in Xovis
Related News
Why 80% of AI Pilots Never Scale — and What the Successful 20% Do Differently
The AI pilot graveyard is large, and it is growing. Across the organisations we have worked with and the research we have reviewed, the pattern…
Read more
AI and Competitive Advantage: Why the Moat Is the Data, Not the Model
Every board strategy conversation about AI now includes a version of the same question: how do we use AI to get ahead, rather than just…
Read more
AI Risk: The 10 Things Every Board Should Know (and Most Don’t)
Corporate governance has always lagged behind the risks it is meant to manage. Boards develop oversight frameworks for risks after those risks have become embedded…
Read more